Concord Medical Services Holdings Ltd: Form 20-F for the period ended Dec 31, 2019
Filed with the SEC on Apr 30, 2020 and accepted by EDGAR at Apr 30, 2020, 16:38 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $20.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $30.8m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | −$2.3m | us-gaap:GrossProfit |
| Operating income | 12 months2019-01-01 to 2019-12-31 | −$62.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2019-01-01 to 2019-12-31 | $4.1m | us-gaap:InterestExpense |
| Income tax | 12 months2019-01-01 to 2019-12-31 | −$5.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2019-01-01 to 2019-12-31 | −$44.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | −$0.61 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | −$28.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $33.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2019-12-31 | $10.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $40.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $617.3m | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $90.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $345.9m | us-gaap:Liabilities |
| Long-term debt | At period end2019-12-31 | $185.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-12-31 | $6.2m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2019-12-31 | $41.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-12-31 | −$17.6m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-12-31 | 130,241,995 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-20-054484. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.